Hongbo Lu, Ph.D., M.B.A.

Partner, Lilly Asia Ventures

Dr. Hongbo Lu is a partner at Lilly Asia Ventures (LAV). Previously, Dr. Lu was with OrbiMed Advisors, serving as its managing director in Asia. She has over 15 years of investment and operational experience in the healthcare industry in the US and in China, including her tenures at OrbiMed, Piper Jaffray & Co. and Zyomyx. Dr. Lu received a Ph.D. in bioengineering from the University of Washington, an MBA from the Haas School of Business at the University of California, Berkeley, and graduated with honors from Tsinghua University in China.

ltBlueRP03 ltBlueRP02left ltBlueRP02left

Terms of Use | Copyright © 2019 Turning Point Therapeutics, Inc. | All Rights Reserved